Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Benefits"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"330 - Economics"
language:"English"
Showing
181
-
200
of
231
Search:
'"Benefits"'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
181
Pharmacoeconomic review report: Dolutegravir/Lamivudine (Dovato) (ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunodeficiency virus type1 (...
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
182
Pharmacoeconomic review report: Netupitant/Palonosetron 300 mg/0.5 mg (Akynzeo) (Purdue pharma)
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
183
Pharmacoeconomic review report: Crisaborole ointment, 2% (Eucrisa) (Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patients two y...
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
184
Pharmacoeconomic review report: Insulin glargine + lixisenatide (Soliqua) (Sanofi-Aventis) : indication : adjunct to diet and exercise to improve glycemic control in adults with ty...
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
185
Pharmacoeconomic review report: Dolutegravir/Rilpivirine (Juluca) : (ViiV healthcare ULC)
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
186
Methoxyflurane in pre-hospital settings : a review of clinical effectiveness, cost-effectiveness and guidelines
by
Yeung, Shirley S. T.
,
Adcock, Lorna
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
187
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
188
Pharmacoeconomic review report: Insulin glargine + lixisenatide (Soliqua) (Sanofi-Aventis) : indication : adjunct to diet and exercise to improve glycemic control in adults with ty...
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
189
Pharmacoeconomic review report: Crisaborole ointment, 2% (Eucrisa) (Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patients two y...
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
190
Pharmacoeconomic review report: Dolutegravir/Rilpivirine (Juluca) : (ViiV healthcare ULC)
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
191
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
192
Pharmacoeconomic review report: Cerliponase Alfa (Brineura) (BioMarin Pharmaceutical (Canada) Inc.) : indication: for the treatment of neuronal ceroid lipofuscinosis type 2 (CLN2)...
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
193
CADTH Canadian Drug Expert Committee recommendation: Insulin degludec (Tresiba -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, types I and II.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
194
Fluoroquinolones for the treatment of urinary tract infection : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Chao, Yi-Sheng
,
Farrah, Kelly
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
195
Fluoroquinolones for the treatment of respiratory tract infections : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Cowling, Tara
,
Farrah, Kelly
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
196
CADTH Canadian Drug Expert Committee recommendation: Tenofovir alafenamide (Vemlidy -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis B.
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
197
Fluoroquinolones for intra-abdominal infections : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Gray, Casey
,
Loshak, Hannah
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
198
Intraoperative mammography for breast cancer surgery : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Williams, D.
,
McCormack, Suzanne
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
199
Pharmacoeconomic review report: Cerliponase Alfa (Brineura) (BioMarin Pharmaceutical (Canada) Inc.) : indication: for the treatment of neuronal ceroid lipofuscinosis type 2 (CLN2)...
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
200
CADTH Canadian Drug Expert Committee recommendation: Eliglustat (Cerdelga -- Sanofi Genzyme) : indication: Type 1 Gaucher disease
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
2
3
4
5
6
7
8
9
10
11
12
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 330 - Economics
Clear Filter
Language: English
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
76
140 - Specific philosophical schools
19
700 - The arts; fine & decorative arts
17
580 - Plants (Botany)
3
600 - Technology
2
more ...
615 - Pharmacology & therapeutics
2
100 - Philosophy & psychology
1
363 - Other social problems & services
1
800 - Literature & rhetoric
1
see all ...
less ...
Language
English
Collection
National Center for Biotechnology Information
231
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
50
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
27
Adcock, Lorna
7
Ho, Chuong
7
Ford, Caitlyn
6
more ...
Grobelna, Aleksandra
5
Argáez, Charlene
4
Chao, Yi-Sheng
4
Gray, Casey
4
McCormack, Suzanne
4
Tran, Khai
4
Banerjee, Srabani
3
Campbell, Kaitryn
3
Loshak, Hannah
3
MacDougall, Danielle
3
Wells, Charlotte
3
Williams, D.
3
Young, Calvin
3
Farrah, Kelly
2
Frey, Nina
2
Jahagirdar, Deepa
2
Kanga, Ismat
2
Poitras, Veronica
2
Visintini, Sarah
2
Adams, Alison
1
Chiu, Stephanie
1
Cowling, Tara
1
De Nanassy, Alina
1
Edge, Rob
1
Harricharan, Sharada
1
Khangura, Sara
1
Klarenbach, Scott
1
Krahn, Murray
1
La Fleur, Philip
1
Lachance, Chantelle
1
Lee, Karen M.
1
Marchand, Dave K.
1
Membe, Stephen K.
1
Narain, Tasha
1
Palylyk-Colwell, Eugenia
1
Picheca, Lory
1
Singh, Sumeet
1
Spry, Carolyn
1
Thompson, Wade
1
Wong, William
1
Wright, Mary-Doug
1
Yeung, Shirley S. T.
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=10&filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&filter%5B%5D=language%3A%22English%22&lookfor=%22Benefits%22&type=Subject
Send by Email
×
Loading...